Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. | Chief Operating Officer | Stock Option (right to buy) | 115K | Apr 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FULC | Fulcrum Therapeutics, Inc. | Apr 26, 2023 | 1 | $0 | 4 | Apr 28, 2023 | Chief Operating Officer |
FULC | Fulcrum Therapeutics, Inc. | Feb 9, 2023 | 1 | $0 | 4 | Feb 13, 2023 | Chief Operating Officer |
FULC | Fulcrum Therapeutics, Inc. | Aug 9, 2022 | 1 | $0 | 4 | Aug 11, 2022 | Chief Operating Officer |
FULC | Fulcrum Therapeutics, Inc. | Aug 9, 2022 | 0 | $0 | 3 | Aug 11, 2022 | Chief Operating Officer |